EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Diagnosing myasthenia gravis versus congenital myasthenia gravis in British Shorthair cats: A case study

Adriana Amfim, Maria Cartacuzencu

Journal of Biological Methods · 21.04.2025 · 12 (2) · e99010059

DOI: 10.14440/jbm.2024.0129 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Biological Methods, online erschienen am 21.04.2025. Verfasst von Adriana Amfim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Faculty of Veterinary Medicine, Spiru Haret University, Bucharest 030045, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myasthenia gravis (MG) is an acquired autoimmune disorder characterized by autoantibodies targeting the neuromuscular junction of skeletal muscles. In contrast, congenital myasthenic syndromes (CMSs) represent a clinically diverse group of genetic disorders affecting the neuromuscular junctions, with early onset and autosomal recessive inheritance. CMSs are particularly prevalent in Devon Rex and Sphynx cats. The gold standard for diagnosing MG in cats involves detecting neuromuscular junction autoantibodies by measuring acetylcholine receptor autoantibodies using radioimmunoassay. For CMS, a definitive diagnosis requires the identification of a causative genetic mutation in addition to clinical signs of skeletal muscle weakness and fatigue. With the Sphynx and Devon Rex breeds, data collected have identified a candidate disease region on the feline C2 chromosome, discovered by employing a genome-wide single-nucleotide polymorphism-based homozygosity mapping strategy. Given that MG is an autoimmune condition, it is treated with steroids, immunosuppressive drugs, and sometimes a thymectomy (surgical removal of the thymus gland). CMS is a set of genetic conditions that do not respond to these treatments. Hence, accurate differential diagnosis is critical. Case presentation: Presented in this case study was a British Shorthair feline which was anamnetically, clinically, paraclinically, and pharmacologically assessed. Genetic testing revealed a positive result for the COLQ gene mutation.

Conclusion

This case study clarified and added criteria to the differential diagnosis between MC and CMS, allowing for more accurate prognostic evaluations and appropriate treatment planning. It also underscores the importance of genetic testing in British Shorthair cats to differentiate between these conditions.

Schlagwörter

Stichwörter der Autor:innen

AutoimmuneBritish shorthairCOLQ geneCongenital myasthenia gravisDiagnostic

Autor:innen und Institutionen

  • Department of Veterinary Medicine, Faculty of Veterinary Medicine, Spiru Haret University, Bucharest 030045, Romania.
  • Veterinaty Clinic, Basarabia, Bucharest 030045, Romania.

Zitieren

APA

Amfim, A., & Cartacuzencu, M. (2025). Diagnosing myasthenia gravis versus congenital myasthenia gravis in British Shorthair cats: A case study. Journal of Biological Methods, 12(2), e99010059. https://doi.org/10.14440/jbm.2024.0129

Vancouver

Amfim A, Cartacuzencu M. Diagnosing myasthenia gravis versus congenital myasthenia gravis in British Shorthair cats: A case study. Journal of Biological Methods. 2025;12(2):e99010059. doi:10.14440/jbm.2024.0129

BibTeX
@article{Amfim2025,
  author = {Amfim, Adriana and Cartacuzencu, Maria},
  title = {Diagnosing myasthenia gravis versus congenital myasthenia gravis in British Shorthair cats: A case study},
  journal = {Journal of Biological Methods},
  year = {2025},
  volume = {12},
  number = {2},
  pages = {e99010059},
  doi = {10.14440/jbm.2024.0129}
}
Kostenlos starten →